IP Verse

Galderma Laboratories, L.P. V. Dr. Reddy'S Laboratories, Ltd. - 1:23-cv-00711

Explore the details of the Galderma Laboratories, L.P. V. Dr. Reddy'S Laboratories, Ltd. case under case number 1:23-cv-00711 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00711
Filing Date
Jun 30, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Galderma Laboratories, L.P. -
Dr. Reddys Laboratories, Inc. -
TCD Royalty Sub LP -

Patents Involved

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US7749532B2
-US8206740B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 30, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (jfm) (Entered: 06/30/2023)PACER Document
Jun 30, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 18, 2023. Date of Expiration of Patent: December 24, 2025 (U.S. Patent No. 8,206,740) & December 19, 2027 (U.S. Patent No. 7,749,532).Thirty Month Stay Deadline: 11/18/2025. (jfm) (Entered: 06/30/2023)PACER Document
Jun 30, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 06/30/2023)PACER Document
Jun 30, 2023COMPLAINT FOR PATENT INFRINGEMENT filed against Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. (Filing fee $ 402, receipt number ADEDC-4169684.) - filed by TCD Royalty Sub LP, Galderma Laboratories, L.P. (Attachments: # 1 Exhibits, # 2 Civil Cover Sheet)(jfm) (Entered: 06/30/2023)PACER Document
Jun 30, 2023Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Drug Royalty III LP 2, Corporate Parent DRI Healthcare Trust for TCD Royalty Sub LP; Corporate Parent Galderma Services Inc. for Galderma Laboratories, L.P. filed by Galderma Laboratories, L.P., TCD Royalty Sub LP. (jfm) (Entered: 06/30/2023)PACER Document
Jun 30, 2023Summons Issued as to Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd. on 6/30/2023. (Attachments: # 1 Summons Issued to Dr. Reddys Laboratories, Ltd.)(jfm) (Entered: 06/30/2023)PACER Document